Sepp-Lorenzino Laura

Track

Insider profile

Performance

Overall performance
3.9
Performance over holding periods
3.9
30 days 90 days 120 days
Average return 11% 8.2% 15.1%
Success rate 81% 68% 82%
Transactions
4 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Sepp-Lorenzino Laura's trades of Intellia Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
28.18
Quantity 2,275
Value US$64,109
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-01-07 2025-01-03
S Sale
60,148 +39.2%
237.87
US$4,153,905 		60,148 +39.2% 237.87 US$4,153,905
2024-01-10 2024-01-08
PlS Planned sale
44,245 -29.5%
219.98
US$3,782,901 		44,245 -29.5% 219.98 US$3,782,901
2024-01-10 2024-01-08
PlS Planned sale
1,721 +22.7%
100.94
US$1,387,413 		1,721 +22.7% 100.94 US$1,387,413
2024-01-08 2024-01-08
PrS Proposed sale
2,275
28.18
US$64,109 		2,275 28.18 US$64,109
2024-01-05 2024-01-03
S Sale
5,532 -10.7%
29.46
US$162,973 		5,532 -10.7% 29.46 US$162,973
2023-01-06 2023-01-05
PlS Planned sale
689 -3.8%
39.10
US$26,940 		689 -3.8% 39.10 US$26,940
2023-01-06 2023-01-05
PlS Planned sale
1,641 -8.2%
38.22
US$62,719 		1,641 -8.2% 38.22 US$62,719
2023-01-06 2023-01-04
S Sale
2,508 -11.2%
37.21
US$93,323 		2,508 -11.2% 37.21 US$93,323
2022-03-03 2022-01-01
S Sale
1,148 -19.3%
112.25
US$128,863 		1,148 -19.3% 112.25 US$128,863